例如:"lncRNA", "apoptosis", "WRKY"

Targeting of the Dosage-Compensated Male X-Chromosome during Early Drosophila Development.

Cell Rep. 2019 Dec 24;29(13):4268-4275.e2
Leila Elizabeth Rieder 1 , William Thomas Jordan 2 , Erica Nicole Larschan 3
Leila Elizabeth Rieder 1 , William Thomas Jordan 2 , Erica Nicole Larschan 3

[No authors listed]

Author information
  • 1 Department of Biology, Emory University, Atlanta, GA 30322, USA. Electronic address: leila.rieder@emory.edu.
  • 2 Department of Molecular Biology, Cellular Biology, and Biochemistry, Brown University, Providence, RI 02912, USA.
  • 3 Department of Molecular Biology, Cellular Biology, and Biochemistry, Brown University, Providence, RI 02912, USA. Electronic address: erica_larschan@brown.edu.

摘要


Dosage compensation, which corrects for the imbalance in X-linked gene expression between XX females and XY males, represents a model for how genes are targeted for coordinated regulation. However, the mechanism by which dosage compensation complexes identify the X chromosome during early development remains unknown because of the difficulty of sexing embryos before zygotic transcription using X- or Y-linked reporter transgenes. We used meiotic drive to sex Drosophila embryos before zygotic transcription and ChIP-seq to measure the dynamics of dosage compensation factor targeting. The Drosophila male-specific lethal dosage compensation complex (MSLc) requires the ubiquitous zinc-finger protein chromatin-linked adaptor for MSL proteins (CLAMP) to identify the X chromosome. We observe a multi-stage process in which MSLc first identifies CLAMP binding sites throughout the genome, followed by concentration at the strongest X-linked MSLc sites. We provide insight into the dynamics of binding site recognition by a large transcription complex during early development.

KEYWORDS: CLAMP, Drosophila, MSL complex, Segregation distorter, chromatin domain, dosage compensation, meiotic drive, transcription factor, zygotic genome activation